medicare tirzepatide coverage is covering GLP-1 weight loss drugs starting July 2026. Here's everything that was just announced Medicare Spending on Ozempic and

January 2025 The lawsuits against GLP-1 drug makers, like Novo Nordisk (Ozempic), are increasing

GLP-1 modulates fat lipid metabolism Fat synthesis includes three aspects: de novo synthesis of saturated fatty acids, extension of fatty acid carbon chains, and synthesis of unsaturated fatty acids

Enhanced insulin sensitivity in adipose tissue allows for increased glucose uptake, helps to lower blood glucose levels, and improves overall metabolic health

Peptide deep dive Sara Talposs article about peptides in Undark (and also published in Stat News) might be the most thorough piece weve read on the subject and thats not just because it quotes APCs Tenille Davis